Several studies have shown that PL EO reduced the PC-3 prostate adenocarcinoma cells’ growth by blocking growth in the Gl phase of the cycle, then suppressing the activity of NF-KB and its signaling pathway [24]. Here, NFKB1 is linked to prostate adenocarcinoma.